Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Multiple sclerosis in Scandinavia and Finland

N Koch-Henriksen1

  • 1Danish Multiple Sclerosis Registry, Rigshospitalet, Copenhagen.

Acta Neurologica Scandinavica. Supplementum
|January 1, 1995
PubMed
Summary

Multiple Sclerosis (MS) incidence rates in Scandinavia and Finland show inconsistent temporal fluctuations. Notably, the typical north-south risk gradient for MS was not observed in the northernmost regions of Norway.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of methodological choices in comparative effectiveness studies: application in natalizumab versus fingolimod comparison among patients with multiple sclerosis.

BMC medical research methodology·2022
Same author

A population-based epidemiological study of neuromyelitis optica spectrum disorder in Hungary.

European journal of neurology·2019
Same author

The neutrophil-to-lymphocyte ratio is associated with multiple sclerosis.

Multiple sclerosis journal - experimental, translational and clinical·2018
Same author

Early versus later treatment start in multiple sclerosis: a register-based cohort study.

European journal of neurology·2018
Same author

Chronic comorbidity in multiple sclerosis is associated with lower incomes and dissolved intimate relationships.

European journal of neurology·2017
Same author

Early safety and efficacy of fingolimod treatment in Denmark.

Acta neurologica Scandinavica·2016

Area of Science:

  • Neurology
  • Epidemiology
  • Environmental Health

Background:

  • Multiple Sclerosis (MS) is a chronic neurological disease with a known geographical distribution.
  • Previous research suggests a north-south gradient in MS risk, particularly in Europe.
  • Understanding temporal trends in MS incidence is crucial for public health planning.

Purpose of the Study:

  • To analyze long-term incidence trends of Multiple Sclerosis (MS) across diverse Scandinavian and Finnish regions.
  • To investigate temporal fluctuations in MS incidence rates over several decades.
  • To evaluate the consistency of the established north-south MS risk gradient at high latitudes.

Main Methods:

  • Systematic review and meta-analysis of epidemiological studies on MS incidence.
  • Inclusion of data from seven geographically distinct areas in Scandinavia and Finland.
  • Analysis of incidence rates spanning several decades to identify temporal patterns.

Main Results:

  • Significant temporal fluctuations in MS incidence were observed in most studied areas.
  • The pattern of these fluctuations was inconsistent across the geographical regions.
  • The lowest MS incidence was recorded in the northernmost parts of Norway, challenging the traditional north-south gradient.

Conclusions:

  • MS incidence in Scandinavia and Finland exhibits complex and inconsistent temporal dynamics.
  • The widely accepted north-south gradient for MS risk may not apply universally, especially at high Arctic latitudes.
  • Further research is needed to elucidate the etiological factors influencing MS epidemiology in these regions.

Related Experiment Videos